Post Profile






More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.
read more

share

Related Posts


Gilead's new drug keeps 56 percent of lymphoma trial patients alive

Health : Reuters: Health

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results...

Moffitt Cancer Center Begins Phase I Clinical Trial of New Immunotherapy

Health : Newswise Medical News

Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person's own immune system to fight cancer. It has several ad...

What is immunotherapy?

Health : The Guardian: Health

New immunotherapy drug IMM-101 brings fresh hope for the effective treatment of serious cancers What is immunotherapy? Immunotherapy is a drug treatment for cancer that stimulates the body’s immune system to recognise and attack tum...

Roche lymphoma drug drives high remission rate, longer survival: study

Health : Reuters: Health

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment ...

Denmark's Genmab looks to immunotherapy for cancer drug encore

Health : Reuters: Health

LONDON (Reuters) - Immunotherapy, which boosts the immune system to fight cancer, could be the next big opportunity for Genmab, potentially driving peak sales of its top-selling drug well past $10 billion a year, its chief executive...

Comments


Copyright © 2016 Regator, LLC